EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Seroprevalence of IgM antibodies against cytomegalovirus (CMV) in HIV patients: single center study

Deema I Fallatah, Hafeez A Adekola, Musa Mohammed, Hajar AlQadeeb

The Journal of Infection in Developing Countries · 2025

DOI: 10.3855/jidc.20552 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2025. Verfasst von Deema I Fallatah und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Sciences, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia. Hauptthemen laut MEDLINE: Immunoglobulin M, Cytomegalovirus Infections, Antibodies, Viral, Cytomegalovirus. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Prince Sattam bin Abdulaziz University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The presence of cytomegalovirus (CMV) immunoglobulin M (IgM) in human immunodeficiency virus (HIV)-positive individuals indicates an active infection or reactivation of the virus. Methodology: This study investigated the seroprevalence of CMV IgM antibodies among HIV-positive individuals attending the Ahmadu Bello University Teaching Hospital in Nigeria.

Results

Fifty nine out of 92 participants who were tested with an enzyme-linked immunosorbent assay (ELISA) were positive for CMV IgM, resulting in a prevalence rate of 64.1%. Analysis of sociodemographic variables revealed a statistically significant association between CMV IgM seropositivity, and both gender and residence of the participants. Clinical variables also indicated a significant association between CMV IgM seropositivity and the duration of HIV infection. Multivariate analysis showed that participants in the 18–29 years age group, those with a secondary education level, the unemployed, and those who had been infected with HIV for 1–3 years were most likely to test positive for CMV infection. Joint and muscle pain were the most commonly reported symptoms among participants.

Conclusions

The high seroprevalence of CMV IgM antibodies found in this study suggests that CMV infection is widespread in the study area. Therefore, it is essential to regularly screen HIV-positive individuals for CMV during routine antiretroviral therapy visits to enable early detection and improve treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin MCytomegalovirus InfectionsAntibodies, ViralCytomegalovirusHIV InfectionsHumansMaleFemaleAdultSeroepidemiologic StudiesYoung AdultAdolescentMiddle AgedNigeriaEnzyme-Linked Immunosorbent AssayHospitals, TeachingCross-Sectional Studies

Stichwörter der Autor:innen

CMVHIVIgMantibodiesinfectionseroprevalence

Substanzen

Immunoglobulin MAntibodies, Viral

Autor:innen und Institutionen

  • Department of Clinical Laboratory Sciences, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia.
  • Department of Molecular Biology and Biotechnology, Nigerian Institute of Medical Research, Yaba, Nigeria.
  • Department of Medicine, Ahmadu Bello University, Zaria, Nigeria.

Förderung

  • Prince Sattam bin Abdulaziz University

Zitieren

APA

Fallatah, D. I., Adekola, H. A., Mohammed, M., & AlQadeeb, H. (2025). Seroprevalence of IgM antibodies against cytomegalovirus (CMV) in HIV patients: single center study. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.20552

Vancouver

Fallatah DI, Adekola HA, Mohammed M, AlQadeeb H. Seroprevalence of IgM antibodies against cytomegalovirus (CMV) in HIV patients: single center study. The Journal of Infection in Developing Countries. 2025. doi:10.3855/jidc.20552

BibTeX
@article{Fallatah2025,
  author = {Fallatah, Deema I and Adekola, Hafeez A and Mohammed, Musa and AlQadeeb, Hajar},
  title = {Seroprevalence of IgM antibodies against cytomegalovirus (CMV) in HIV patients: single center study},
  journal = {The Journal of Infection in Developing Countries},
  year = {2025},
  doi = {10.3855/jidc.20552}
}
Kostenlos starten →